<< 1 2 3 4 5  ... >> 



Chip-based blood test for multiple myeloma could help make bone biopsies a relic of the past
Published: 4/19/2018

A clinical trial study led by Priyanka Sharma, MD, breast oncologist at The University of Kansas Cancer Center, demonstrates that triple-negative breast cancer patients fare better when treated with a common adjuvant chemotherapy combination.

Triple-Negative Breast Cancer Study Reveals Multiple Findings
Published: 4/17/2018

A clinical trial study led by Priyanka Sharma, MD, breast oncologist at The University of Kansas Cancer Center, demonstrates that triple-negative breast cancer patients fare better when treated with a common adjuvant chemotherapy combination.

KU Cancer Center-Discovered Anti-Cancer Drug to be presented at AACR 2018 Meeting
Published: 4/12/2018

The University of Kansas Cancer Center will present preclinical evidence supporting Ciclopirox Prodrug (CPX-POM), an anti-cancer agent currently in Phase I clinical trials, at the American Association for Cancer Research (AACR) 2018 Annual Meeting in Chicago.

Exosomes Possible Biomarker for Targeted Sarcoma Therapy
Published: 3/9/2018

Researchers at The University of Kansas Cancer Center are studying tiny vesicles that may help lead to more targeted cancer therapies. Also called exosomes, these microvesicles act as “fingerprints” of a tumor’s identity, providing early clues to cancer cases.

First Patient Dosed with Ciclopirox Prodrug in Phase I Trial in Patients with Advanced Solid Tumors
Published: 3/1/2018

CicloMed LLC, a biotechnology company developing novel treatments for bladder cancer, announced that the first patient has been dosed in a Phase I clinical trial.

<< 1 2 3 4 5  ... >> 

News


Browse by Year
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Expert Care

find a doctor

Named Among US News & World Reports Best Hospitals for Cancer care 2017-18

Request an Appointment

913-588-1227


Toll-Free

844-323-1227